Clinical trial
Feasibility Study of Head and Intraocular Trauma Test (HITT) Device for Potential Detection of Brain Dysfunction
NCT03249818 is registered in ClinicalTrials.gov with Rebiscan, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of Head and Intraocular Trauma Test (HITT) Device for Potential Detection of Brain Dysfunction
- Lead sponsor
- Rebiscan, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 22, 2017
- Completion date
- February 28, 2018
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.